Open the label for Ozempic, Wegovy, Mounjaro or Zepbound and the first thing you see is a box about thyroid tumors. It can be unsettling to read. Here is what the box says, where it comes from, who it rules out, and what to watch for, all from the labels themselves.
1.What is a boxed warning?
A boxed warning is the most prominent warning on a prescription label. It's printed inside a box at the very top, before anything else. The Ozempic, Wegovy, Mounjaro and Zepbound labels all open with the same one: WARNING: RISK OF THYROID C-CELL TUMORS.
A box tells you the topic matters. It doesn't, by itself, say how likely something is. For that you have to read what's inside it.
2.Where does the thyroid warning come from?
Your thyroid is a small gland in your neck. Some of its cells, called C cells, make a hormone called calcitonin. Medullary thyroid carcinoma, or MTC, is "a rare cancer that happens when C cells in your thyroid grow out of control" (MedlinePlus).
The warning comes from animal studies run before these medicines were approved. Each label describes them in section 13.1:
- Semaglutide (Ozempic, Wegovy) was given to mice and rats in 2-year studies. Both had more thyroid C-cell tumors, at exposures similar to what people get.
- Tirzepatide (Mounjaro, Zepbound) was given to rats in a 2-year study, and they had more C-cell tumors. A 6-month study in a special kind of lab mouse did not cause tumors. So for tirzepatide, the labels say "in rats."
- More with more. The labels call the effect in rodents "dose-dependent and treatment-duration-dependent": more tumors showed up with higher doses and longer use.
“In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures.”
3.Does it happen in people?
This is the key line, and the labels answer it plainly: nobody knows. Rodent studies showed the tumors. Whether the same thing happens in people has not been worked out.
“It is unknown whether OZEMPIC causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.”
The Wegovy, Mounjaro and Zepbound boxes use the same wording with their own names. "Unknown" is not the same as "yes," and it's not the same as "no." Because it's unknown, the labels take a careful approach for the people with the most at stake.
4.Who should not take a GLP-1 because of this?
Every one of these labels lists the same two groups. They're contraindicated, which means the medicine should not be used:
- Anyone with a personal or family history of MTC, the rare thyroid cancer that starts in C cells.
- Anyone with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), an endocrine system condition.
“Do not use OZEMPIC if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).”
If you aren't sure about your family's history, that's worth raising with your prescriber before you start. It's exactly the kind of thing they want to know.
5.What signs should I tell my doctor about?
The Medication Guide, the part of the label written for patients, lists four signs. Tell your healthcare provider if you get:
- a lump or swelling in your neck
- hoarseness
- trouble swallowing
- shortness of breath
The Medication Guide says these may be symptoms of thyroid cancer. Many things can cause them, so they don't mean you have it. They do mean it's time to call.
6.Do I need thyroid tests or scans?
Not as a routine, according to the labels. They say regular calcitonin blood tests or thyroid ultrasounds are "of uncertain value for early detection of MTC." The Ozempic and Zepbound labels add that this kind of monitoring may raise the risk of unnecessary procedures.
That doesn't mean tests are never done. If a lump turns up, or your doctor has a reason to look, they'll decide what's needed. The point is that screening everyone just because they take a GLP-1 isn't what the labels recommend.
7.Is this the same for every GLP-1?
| Medicine | Studies showed tumors in | In people | Not for |
|---|---|---|---|
| Ozempic (semaglutide) | Rodents (mice and rats) | Unknown | MTC history, MEN 2 |
| Wegovy (semaglutide) | Rodents (mice and rats) | Unknown | MTC history, MEN 2 |
| Mounjaro (tirzepatide) | Rats | Unknown | MTC history, MEN 2 |
| Zepbound (tirzepatide) | Rats | Unknown | MTC history, MEN 2 |
The details of the animal studies differ by ingredient. What the labels tell people is the same: unknown in humans, the same two groups ruled out, the same four signs to report.
How Checkin helps with side effects
Checkin is a free AI companion for GLP-1s that you text. For this part of life on a GLP-1, it does three things:
- Text how you feel, any time
Plain answers from the FDA label, with a picture when it helps.
- It checks in two days after your shot
When many side effects show up, so you're not sorting it out alone.
- Warning signs get a straight answer
If something sounds serious, it tells you to call your doctor or 911 right away.



